Inventor · disambiguated record
Steven D. Levin
Also filed as: LEVIN STEVEN D
22 granted patents·25 pending applications·297 citations·filing 2001–2025
96Inventor score
Files withZYMOGENETICS INC24LEVIN STEVEN D8GAO ZEREN6LEWIS KATHERINE E4HEALTH RES INC ROSEWELL PARK D1
Top patents by PatentIndex Score
47 records- 0197US7910703B2Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of useZYMOGENETICS INC·Filed 2008·Granted Mar 22, 2011·46 cites·14 claims
- 0296US9695238B2Screening method for inhibitors of binding of zBR7R1 to CD155ZYMOGENETICS INC·Filed 2016·Granted Jul 4, 2017·22 cites·14 claims
- 0396US7790862B2IL-17 and IL-23 antagonists and methods of using the sameZYMOGENETICS INC·Filed 2007·Granted Sep 7, 2010·49 cites·14 claims
- 0495US9994637B2Method of treating CD155 expressing cancersZYMOGENETICS INC·Filed 2017·Granted Jun 12, 2018·11 cites·10 claims
- 0595US8333968B2Methods of inhibiting inflammation with antagonists to IL-17A, IL-17F, and IL-23P19LEWIS KATHERINE E·Filed 2011·Granted Dec 18, 2012·30 cites·14 claims
- 0693US8496936B2Antagonists of IL-17A, IL-17F, and IL-23P19LEWIS KATHERINE E·Filed 2012·Granted Jul 30, 2013·19 cites·2 claims
- 0792US7910540B2Soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners and methods of using in inflammationZYMOGENETICS INC·Filed 2005·Granted Mar 22, 2011·17 cites·6 claims
- 0892US7842665B2IL-17A and IL-17F antagonistsZYMOGENETICS INC·Filed 2009·Granted Nov 30, 2010·11 cites·6 claims
- 0989US8268773B2Methods of treating multiple sclerosis (MS) using an IL-17A and IL-17F antagonistPRESNELL SCOTT R·Filed 2011·Granted Sep 18, 2012·12 cites·6 claims
- 1088US8992922B2Antagonists of IL-17A, IL-17F, and IL-23P19ZYMOGENETICS INC·Filed 2013·Granted Mar 31, 2015·7 cites·3 claims
- 1188US7622116B2Method of treating inflammation using soluble IL-17RCX4ZYMOGENETICS INC·Filed 2007·Granted Nov 24, 2009·10 cites·15 claims
- 1287US8822642B2Dimeric fusion proteins and related compositions and methodsLEVIN STEVEN D·Filed 2011·Granted Sep 2, 2014·27 cites·15 claims
- 1383US8227579B2IL-23 antagonistsLEWIS KATHERINE E·Filed 2010·Granted Jul 24, 2012·8 cites·5 claims
- 1482US9464134B2Polynucleotides encoding antagonists of IL-17A, IL-17F, and IL-23p19ZYMOGENETICS INC·Filed 2015·Granted Oct 11, 2016·2 cites·5 claims
- 1582US6955895B2Thymic stromal lymphopoietin receptor molecules and uses thereofHEALTH RES INC ROSEWELL PARK D·Filed 2001·Granted Oct 18, 2005·16 cites·15 claims
- 1680US2022002419A1Compositions and methods for modulating immune responsesZYMOGENETICS INC·Filed 2021·Application pending·0 cites
- 1779US7790676B2Soluble IL-17RA/RC fusion proteinsZYMOGENETICS INC·Filed 2008·Granted Sep 7, 2010·3 cites·25 claims
- 1879US2025297010A1Compositions and methods for modulating immune responsesZYMOGENETICS INC·Filed 2025·Application pending·0 cites
- 1978US9994634B2Use of an IL-17/IL-23 bispecific antibody for treating inflammationZYMOGENETICS INC·Filed 2016·Granted Jun 12, 2018·1 cites·4 claims
- 2076US8093355B2Soluble IL-17RCx4 and fusion proteins thereofKUESTNER ROLF E·Filed 2009·Granted Jan 10, 2012·3 cites·4 claims
- 2176US8084231B2Soluble IL-17RA/RC fusion proteins and related methodsLEVIN STEVEN D·Filed 2010·Granted Dec 27, 2011·3 cites·28 claims
- 2272US2019375843A1Compositions and methods for modulating immune responsesZYMOGENETICS INC·Filed 2019·Application pending·0 cites
- 2369US2018251556A1Compositions and methods for modulating immune responsesZYMOGENETICS INC·Filed 2018·Application pending·0 cites
- 2468US10562967B2Treating inflammation with IL-17/IL-23 bispecific antibodiesZYMOGENETICS INC·Filed 2018·Granted Feb 18, 2020·0 cites·4 claims
- 2568US2009156495A1Compositions and methods for modulating immune responsesZYMOGENETICS INC·Filed 2008·Application pending·0 cites
- 2667US2015152160A1Compositions and methods for modulating immune responsesZYMOGENETICS INC·Filed 2014·Application pending·0 cites
- 2762US2012219540A1Compositions and methods for modulating immune responsesGAO ZEREN·Filed 2012·Application pending·0 cites
- 2861US2007054360A1Compositions and methods for modulating immune responsesGAO ZEREN·Filed 2006·Application pending·0 cites
- 2960US2007048257A1Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammationZYMOGENETICS INC·Filed 2006·Application pending·0 cites
- 3060US2007048826A1Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammationZYMOGENETICS INC·Filed 2006·Application pending·0 cites
- 3159US7402659B2Thymic stromal lymphopoietin receptor molecules and uses thereofWHITEHEAD BIOMEDICAL INST·Filed 2005·Granted Jul 22, 2008·0 cites·19 claims
- 3259US2009175876A1Methods of using phhla2 to co-stimulate t-cellsZYMOGENETICS INC·Filed 2009·Application pending·0 cites
- 3358US8242072B2Methods of treating inflammation using soluble IL-17RA/RC fusion proteinsLEVIN STEVEN D·Filed 2011·Granted Aug 14, 2012·0 cites·14 claims
- 3458US2010316646A1Compositions and methods for modulating immune responsesZYMOGENETICS INC·Filed 2010·Application pending·0 cites
- 3557US2012289684A1Methods of treating inflammation using soluble il-17ra/rc fusion proteinsLEVIN STEVEN D·Filed 2012·Application pending·0 cites
- 3656US2007280942A1Compositions and methods for modulating immune responsesLEVIN STEVEN D·Filed 2007·Application pending·0 cites
- 3755US2007249533A1Il-17a and il-17f antagonists and methods of using the sameLEVIN STEVEN D·Filed 2007·Application pending·0 cites
- 3855US2007049524A1Soluble zcytor21, anti-zcytor21 antibodies and binding partners and methods of using in inflammationZYMOGENETICS INC·Filed 2006·Application pending·0 cites
- 3955US2007049525A1Soluble zcytor21, anti-zcytor21 antibodies and binding partners and methods of using in inflammationZYMOGENETICS INC·Filed 2006·Application pending·0 cites
- 4052US2006142192A1Soluble ZcytoR21, anti-ZcytoR21 antibodies and binding partners and methods of using in inflammationGAO ZEREN·Filed 2005·Application pending·0 cites
- 4151US2007053903A1Methods of using pHHLA2 to co-stimulate T-cellsGAO ZEREN·Filed 2006·Application pending·0 cites
- 4250US2012295310A1Nucleic acids encoding anti-il-23 antibodiesLEWIS KATHERINE E·Filed 2012·Application pending·0 cites
- 4350US2009202534A1Compositions and methods for modulating immune responsesLEVIN STEVEN D·Filed 2008·Application pending·0 cites
- 4445US2007238658A1IL-17A and IL-17F Antagonists and Methods of Using the SameLEVIN STEVEN D·Filed 2006·Application pending·0 cites
- 4544US2007129302A1Il-17c antagonists and methods of using the sameGAO ZEREN·Filed 2006·Application pending·0 cites
- 4641US2007197441A1Truncated il-17ra soluble receptor and methods of using in inflammationRIXON MARK W·Filed 2007·Application pending·0 cites
- 4740US2006286092A1Methods of using pNKp30, a member of the B7 family, to modulate the immune systemGAO ZEREN·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven D. Levin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →